R9U2.F
Green Thumb Industries Inc.

Healthcare · Drug Manufacturers - Specialty & Generic · valued as of 2026-11-03 · statements 2025-12-31

Average Intrinsic Value

1.41B USD

Market Cap

1.38B USD

Margin of Safety

2.2%

Intrinsic / Market Ratio

1.02×

Projections, not exact values. Intrinsic Values are projected from each company's past reports. They show which stocks look cheap compared with the others, not exactly what a stock is worth.

How Each Value Is Built

The screener's three formulas on the reported figures. Each card reads the same way: the value as a sum of numbered terms, each term's calculation opened under it, from the reported figures to the value. The list ranks companies by their plain average over the market cap.

EPV + Growth

502.05M USD

what the normal year's earnings are worth for ever, plus growth that pays

Profit

1.86B USD

15 years of cash the shareholders can take out, and the equity left at year 15

FCFF

1.86B USD

15 years of cash for shareholders and lenders, less what is owed

Intrinsic Value

1.41B USD

the plain average of the three, uncapped, as the screener averages them

Intrinsic Value

1.41B USD

from the sum above

Market Cap

1.38B USD

the price on the date above times the shares

Intrinsic Value ÷ Market Cap

1.02×

the ratio the screener ranks by; Margin of Safety +2.2% (1 − Market Cap ÷ Intrinsic Value)

Each card below builds one of the three values from the reported years.

Earnings power value plus growth: 502.05M USD
What the normal year's operating profit after tax is worth if it lasts for ever, plus what the new investment adds beyond its cost, less the net debt that comes before the shareholders (or plus the net cash).
①EPV (earnings power value)778.94M USD
−②Net Debt Today276.89M USD
+③Growth Value0 USD
=Value502.05M USD

EPV of the Operations (NOPAT over WACC)

778.94M USD

Net debt today

-276.89M USD

Growth Value

0 USD

Value

502.05M USD

①EPV (earnings power value)

778.94M USD

②Net Debt Today

276.89M USD

③Growth Value

0 USD

Market value

Market Cap1.38B USD

The price on the date above times the shares.

Value vs market

Margin of Safety-174.4%

1 minus the market cap as a share of the value.

Profit value: today's value of the shareholders' equity, from the cash it can pay them (FCFE): 1.86B USD
Fifteen years of free cash flow to equity (FCFE), each brought to today at the cost of equity, plus the equity at year 15 brought to today.

The projection was not made (a profit at or below zero in the latest three years), so the value is the book value today, 1.86B USD, as the screener leaves it.

①Present Value of the 15 Years of FCFE

Not in the value

②Equity at Year 15, Today

Not in the value

Market value

Market Cap1.38B USD

The price on the date above times the shares.

Value vs market

Margin of Safety+26.0%

1 minus the market cap as a share of the value.

FCFF value: today's value of the shareholders' equity, from the cash the firm can pay its shareholders and lenders (FCFF): 1.86B USD
Fifteen years of free cash flow to the firm (FCFF), each brought to today at the WACC, plus the invested capital at year 15 brought to today, less the net debt today (or plus the net cash).

The projection was not made (a change in working capital above half the operating profit in the latest three years), so the value is the book value today, 1.86B USD, as the screener leaves it.

①Present Value of the 15 Years of FCFF

Not in the value

②Invested Capital at Year 15, Today

Not in the value

③Net Debt Today

Not in the value

Market value

Market Cap1.38B USD

The price on the date above times the shares.

Value vs market

Margin of Safety+26.0%

1 minus the market cap as a share of the value.

The Rates and the Capital the Values Read

The WACC and the cost of equity each value is discounted at, the book value and the net debt each starts from, and the seven quality metrics, from the same run.

WACC: 7.72%
Cost of Equity =Risk-Free Rate 4.50%+Beta 0.95×Market Risk Premium 6.00%= 10.22%

The yearly return the shareholders require for the risk they carry; it is the rate that brings their future cash to today.

Tax Rate for WACC =Tax Provision 147.45M USDPretax Income 263.62M USD= 55.93%

The tax the interest saves.

Interest Expense =EBIT 283.66M USD−Pretax Income 263.62M USD= 20.04M USD

The interest the company paid: EBIT is the profit before tax plus the interest.

Cost of Debt =Interest Expense 20.04M USDTotal Debt 560.76M USD×(1 − Tax Rate for WACC 55.93%)= 1.57%

What the lenders are paid a year after the tax the interest saves.

Debt Weight =Total Debt 560.76M USDMarket Cap + Total Debt 1.38B USD + 560.76M USD= 28.93%

The part of the capital the lenders put in, at market value.

WACC =Equity Weight 71.07%×Cost of Equity 10.22%+Debt Weight 28.93%×Cost of Debt 1.57%= 7.72%

Weighted average cost of capital: the yearly return the shareholders and the lenders together require, weighted by what each puts in; the rate that brings the firm's future cash to today.

Book value and net debt today
Both from the balance sheet of the newest quarter, 2026-06-30.

Total Assets 2.82B USD − Total Liabilities 955.59M USD = Book Value Today 1.86B USD

Total Debt 560.76M USD − Cash and Short-Term Investments 283.87M USD = Net Debt Today 276.89M USD

The book value is what Profit starts from and what stands when a projection is not made; the book value plus the net debt is what FCFF starts from; the net debt comes off Greenwald's and FCFF's values before the shareholders.

Quality metrics
Read beside the value, never a condition for it: every company is valued, and a filter in the list is the reader's choice.
MetricFrom
Share dilutionShares Today ÷ Shares Two Years Back − 1-7.1%at most 5%passes218,563,581 / 235,393,892
Accrual quality(Operating Cash Flow − Net Income) ÷ Total Assets6.4%at least -10.0%passes(295.22M USD − 114.27M USD) ÷ 2.82B USD
Price to bookMarket Cap ÷ Book Value Today0.74×at most 3×passes1.38B USD ÷ 1.86B USD
Operating marginOperating Income ÷ Revenue11.7%above 10.0%passes137.84M USD ÷ 1.18B USD
Revenue growthRevenue ÷ Revenue a Year Before − 13.4%above 10.0%does not pass1.18B USD / 1.14B USD
Net cash(Cash − Total Debt) ÷ Market Cap-20.1%above -30%passes(283.87M USD − 560.76M USD) ÷ 1.38B USD
Operating efficiencyOperating Income ÷ Gross Profit24.0%above 25.0%does not pass137.84M USD ÷ 575.47M USD

Market Data

The provider's ratios and the analysts' consensus beside the argument; none of them enters a value.

Share price

5.63 EUR

Enterprise value

1.54B EUR

the provider's own figure

EV / EBITDA

5.72×

Price / book

0.74×

the provider's book

Price / earnings

12.22×

Return on equity

6.9%

the provider's figure, not this page's

Profit margin

10.5%

Revenue growth

4.6%

Analyst target, mean

—

Analysts

—

opinions in the consensus

Financial Statements

The annual lines the screener holds, year by year, in USD at each period's rate; the figures this valuation read are in its calculation above.

USD2022202320242025
Income statement

Revenue

1.02B1.06B1.14B1.18B

Gross profit

504.47M527.02M601.71M575.47M

Operating income

209.78M184.82M224.65M137.84M

EBITDA

operating income before depreciation and amortisation

270.55M324.47M392.39M480.87M

Pretax income

108.54M156.21M200.34M263.62M

Net income

11.99M36.30M73.16M114.27M

Normalized income

net income without one-off items, as the data provider prints it; Profit's line when printed

75.62M48.31M73.55M-425.28K

R&D

————
Balance sheet, year end

Total assets

2.44B2.49B2.54B2.79B

Total liabilities

768.86M787.59M748.68M880.29M

Shareholders' equity

the equity the parent's shareholders own, as printed, without minority interest; the book value the values read is total assets less total liabilities, in Book Value and Net Debt above

1.67B1.70B1.79B1.91B

Total debt

536.39M570.85M531.23M518.87M

Cash and equivalents

177.86M161.80M171.86M274.57M

Net PP&E

fixed assets after depreciation

801.03M926.40M963.26M931.49M

Working capital

current assets less current liabilities

204.98M216.93M239.17M400.26M
Cash flow

Operating cash flow

158.72M225.19M195.38M295.22M

Capital expenditure

paid out, so below zero

-179.68M-220.26M-80.27M-81.15M

Depreciation and amortisation

140.79M149.17M167.76M197.21M

Free cash flow

operating cash flow plus capital expenditure

-20.96M4.94M115.11M214.07M